On the other hand and supporting a potential immune relevance, the initial discovery of the splicing event and spliced epitopes was based on the identification of patient-derived CD8+ T cells reactive towards spliced epitopes generated from tumor antigens (Hanada et al., 2004; Vigneron et al., 2004). This evidence concerns the gene CD8A and neoplasm.